Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03705741
Other study ID # 2018/246
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 5, 2018
Est. completion date July 1, 2025

Study information

Verified date September 2023
Source Värmland County Council, Sweden
Contact Karolina Petrov Fieril, PhD
Phone +46730720265
Email fieril@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Maintaining a physically active lifestyle is associated with many health benefits, including lower risk of cardiovascular disease, diabetes, hypertension, some type of cancer, and depression . Pregnant, healthy women are recommended to do 30 minutes or more of light to moderate exercise a day, although most women in the Western world do not follow current recommendations and decrease their exercise level. Benefits of exercise during pregnancy are several, including a protective effect against the development of gestational diabetes mellitus, reduced pregnancy related low back pain, and risk of caesarean delivery. On the contrary, a recent review concludes that sedentary behaviors are associated with higher levels of C Reactive Protein and LDL Cholesterol, a larger newborn abdominal circumference, and macrosomia. Previous studies show that exercise during pregnancy is associated with improvements in psychological well-being among previously sedentary women. Only a few RCT's have studied resistance exercise during pregnancy. These studies have found reduced fatigue and reduced need of insulin among women with gestational diabetes mellitus who did resistance exercise, with no adverse effects on fetus or the pregnant woman. The aim of this study is to evaluate the efficacy of regular light -to-moderate resistance exercise among sedentary pregnant woman, with regard to fatigue, health related quality of life, pain location and intensity, body weight gain, blood pressure, and childbirth outcomes.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date July 1, 2025
Est. primary completion date May 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Single pregnancy and =18 of age - Ability to understand verbal and written Swedish - Inclusion during gestational week 20+0-20+6. Exclusion Criteria: - Follows the recommendation regarding contraindications according to the American Collage of Obstetricians and Gynecologists 2002 - Severe pain from the pelvic or the back - Regular exercise >150 minutes per week the last six months

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Resistance exercise
Resistance exercise twice a week during pregnancy week 23-34.

Locations

Country Name City State
Sweden Fysioterapimottagningen Gripen Karlstad

Sponsors (1)

Lead Sponsor Collaborator
Värmland County Council, Sweden

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in fatigue Visual Analogue Scale (VAS) 0-100 millimeters. It is a psychometric scale and measure self-reported fatigue from 0, "no fatigue" to 100, "very great fatigue". The scale is a streight horizontal line. Register at gestational week 22 and 34
Secondary Change in anxiety / depression Visual Analogue Scale (VAS) 0-100 millimeters. It is a psychometric scale and measure self-reported anxiety/depression from 0, "no anxiety/depression" to 100, "very great anxiety/depression". The scale is a streight horizontal line. Register at gestational week 22 and 34
Secondary Change in pain Visual Analogue Scale (VAS) 0-100 millimeters. It is a psychometric scale and measure the intensity of pain from 0, "none pain" to 100, "extreme amount of pain". The scale is a streight horizontal line. Register at gestational week 22 and 34
Secondary Change in Health Related Quality of Life Visual Analogue Scale (EQ-VAS). Mark health status on the day on a 20 centimeters vertical scale with end points of 0 and 100. There are notes at the both ends of the scale that the bottom rate (0) corresponds to " the worst health you can imagine", and the highest rate (100) corresponds to "the best health you can imagine". Register at gestational week 22 and 34
Secondary Change in blood pressure Systolic and Diastolic From perinatal records. Registered at gestational week 22 and 34
Secondary Change in weight gain kilogram from perinatal records. Registered at gestational week 22 and 34
Secondary Gestational Diabetes Mellitus (GDM) Development of GDM from perinatal records. Registered at gestational week 34
Secondary Change in exercise Minutes a day. (Walks, light, moderate, vigorous intensity). Registered at gestational week 22 and 34
Secondary Birth weight kilogram from perinatal records at birth (gestational week 40)
Secondary Birth length centimeters from perinatal records at birth (gestational week 40)
Secondary Gestational age days From perinatal records at birth (gestational week 40)
Secondary Acute cesarean section rate from perinatal records at birth (gestational week 40)
Secondary Macrosomia rate of birth with macrosomia from perinatal records at birth (gestational week 40)
See also
  Status Clinical Trial Phase
Completed NCT05017974 - Research on Improving Sleep During Pregnancy N/A
Completed NCT03284515 - Vaccination In Pregnancy Gene Signature: VIP Signature Study
Recruiting NCT05969795 - Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support Phase 1
Recruiting NCT06051201 - Innovation for Small-scale Experiments: ReceptIVFity Test N/A
Recruiting NCT04828382 - Prospective Study of Pregnancy in Women With Cystic Fibrosis
Enrolling by invitation NCT04527926 - STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy N/A
Recruiting NCT04278651 - Early Antenatal Support for Iron Deficiency Anemia Phase 4
Recruiting NCT04405700 - Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Recruiting NCT06258902 - Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
Completed NCT05487196 - Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia Phase 2
Completed NCT03750968 - Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects Phase 2
Enrolling by invitation NCT06127277 - Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care N/A
Completed NCT05897697 - Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
Recruiting NCT05899101 - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Completed NCT04296396 - Opioid Prescription After Cesarean Trial Phase 3
Not yet recruiting NCT06069856 - Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06069869 - Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06079918 - Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania Phase 3
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A